Skip to main content

Featured

Benefit Payments Before Christmas: What Lands When, and How to Plan Around It

  Canadian Money Brief Benefit Payments Before Christmas: What Lands When, and How to Plan Around It Sunday, November 15, 2026 If a government payment is part of your monthly budget, the next five weeks have an unusual rhythm. Two payments arrive this week, one more lands the day before Black Friday, and December's cheques come early. Knowing the order is the easiest way to avoid a short month. This Week: Two Payments, Back to Back The Canada Disability Benefit is paid Thursday, Nov 19, and the Canada Child Benefit follows on Friday, Nov 20. The disability benefit pays up to $204.20 a month, and Ottawa pays it on the third Thursday of every month. The CCB pays up to $679.75 a month for each child under 6 and $573.58 for each child aged 6 to 17. Those are maximums, and they go to families with adjusted family net income under $38,237. The amount shrinks as income rises above that level. Black Friday Falls the Day After CPP and OAS CPP, OAS and GIS all pay on Thursday, Nov 26. Bla...

article

U.S. Drug Tariffs: A Looming Crisis for Global Supply Chains


The U.S. government's decision to impose tariffs on pharmaceutical imports has sent shockwaves through the healthcare industry, raising concerns about potential drug shortages and skyrocketing costs. Industry leaders warn that these tariffs could disrupt critical supply chains, affecting the availability of essential medications and medical devices.

Johnson & Johnson CEO Joaquin Duato has voiced concerns over the impact of these tariffs, advocating for tax incentives instead of trade barriers to support domestic drug manufacturing Warns Tariffs Could Disrupt U.S. Drug Supply Chains](https://www.theglobeandmail.com/investing/markets/stocks/LLY-N/pressreleases/31903548/jj-ceo-jnj-warns-tariffs-could-disrupt-us-drug-supply-chains/). Meanwhile, a recent survey indicates that healthcare executives anticipate significant price hikes, with some predicting an 18% increase in medical equipment costs and a 33% rise in critical device prices.

The American Hospital Association has urged the administration to reconsider these tariffs, emphasizing the reliance of U.S. healthcare providers on international sources for life-saving drugs and supplies. Experts caution that while the tariffs aim to boost domestic production, the transition could take years, leaving patients vulnerable to shortages and inflated prices.

As pharmaceutical companies scramble to adjust their supply chains, the industry faces an uncertain future. Whether these tariffs will achieve their intended goal or exacerbate existing challenges remains to be seen. Policymakers must weigh the long-term consequences carefully to ensure that patient care and affordability are not compromised.

Comments